Xybion Announces Release of New and Improved Web-Based SaaS Preclinical LIMS Platform: Pristima Web 10.0
Princeton, New Jersey, October 15, 2024 – Xybion, a global leader in LIMS and AI-enabled software solutions provider, is excited to announce the launch of Pristima Web 10.0—the most advanced preclinical LIMS platform available today. This platform-based unified system can replace solutions with multiple weakly integrated systems that break frequently and increase security risks. Designed to streamline and optimize preclinical research, Pristima Web 10.0 delivers powerful capabilities that help design the right protocols, boost study execution efficiency, manage data and predictive models for better and faster outcomes. Pristima Web 10.0 is the most versatile software covering all therapeutic areas including Cardiovascular, Oncology, Infectious Diseases, Respiratory, Immunology, Gastroenterology, Metabolism and Endocrinology for various study types such as single and multi-dose Toxicology, Safety Pharmacology, Dose range finding, Toxicokinetics, Carcinogenicity, Fertility, and early embryonic development.
